Real-time enrollment status for this glaucoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT05401357 |
| Recruiting Status | Recruiting |
| Condition | Glaucoma |
| Phase | Clinical Trial |
| Target Enrollment | 168 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Amneal Pharmaceuticals, LLC |
| Last Updated on CT.gov | August 10, 2022 (Aug 10, 2022) |
As of March 2, 2026: Clinical trial NCT05401357 is currently recruiting participants. This clinical trial study for glaucoma is actively seeking new participants at 9 locations across the United States. The study is sponsored by Amneal Pharmaceuticals, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05401357 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05401357 was last updated Aug 10, 2022 (August 10, 2022). HelloStudys verifies this status automatically.